Navegar

Colección

Datos Estadísticas

Lista de

cancer invasion
14
"Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer" (2012) Schillaci, R.;Guzmán, P.;Cayrol, F. (...)Elizalde, P.V. BMC Cancer. 12
"Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein" (2012) Goddio, M.V.;Gattelli, A.;Slomiansky, V. (...)Kordon, E.C. Breast Cancer Research and Treatment. 135(3):749-758
"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: An international collaborative study" (2010) Daly, A.F.;Tichomirowa, M.A.;Petrossians, P. (...)Beckers, A. Journal of Clinical Endocrinology and Metabolism. 95(11):E373-E383
"Emerging roles of ATF2 and the dynamic AP1 network in cancer" (2010) Lopez-Bergami, P.; Lau, E.; Ronai, Z. Nature Reviews Cancer. 10(1):65-76
"Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells" (2009) Gueron, G.;De Siervi, A.;Ferrando, M. (...)Vazquez, E.S. Molecular Cancer Research. 7(11):1745-1755
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"MMTV-induced pregnancy-dependent mammary tumors: Early history and new perspectives" (2008) Kordon, E.C. Journal of Mammary Gland Biology and Neoplasia. 13(3):289-297
"Nerve growth factor and retinoic acid inhibit proliferation and invasion in thyroid tumor cells" (2000) Páez Pereda, M.;Missale, C.;Grübler, Y. (...)Stalla, G.K. Molecular and Cellular Endocrinology. 167(1-2):99-106
"Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion" (1999) Páez Pereda, M.;Hopfner, U.;Pagotto, U. (...)Stalla, G.K. British Journal of Cancer. 81(3):381-386
"The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo." (1998) Bover, L.;Barrio, M.;Bravo, A.I. (...)Mordoh, J. Cellular and molecular biology (Noisy-le-Grand, France). 44(3):493-504
"Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells" (1997) Fernanda Ledda, M.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Nature Medicine. 3(2):171-176
"Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model." (1996) Ledda, M.F.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Cellular and molecular biology (Noisy-le-Grand, France). 42(5):769-778
"Expression of gelatinise/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasion" (1992) Daniel Bonfil, R.;Medina, P.A.;Gómez, D.E. (...)Bustuoabad, O.D. Clinical & Experimental Metastasis. 10(3):211-220